Sophiris names Woods CEO
Sophiris Bio Inc. (TSX:SHS) hired Randall Woods as CEO. Woods is the former president and CEO of NovaCardia Inc., which Merck & Co. Inc. (NYSE:MRK) acquired in 2007. Sophiris (formerly Protox Therapeutics Inc.) is developing PRX302 for benign prosta..
Original Article: Sophiris names Woods CEO
NEXT ARTICLE